With a revenue increase of 10.63% in the second quarter 2026, year on year to cumulative value of $2,436 million, Exelixis Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,123,731, this marks a new company high.
Within the Healthcare sector Employees of 28 other companies have achieved higher revenue per employee. While Exelixis Inc 's total ranking has deteriorated compared to the previous quarter from 282 to 414. Exelixis Inc has 1,147 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EXEL Revenue per Employee	(Jul 03 2026) II. Quarter	(Apr 03 2026) I. Quarter	(Jan 02 2026) IV. Quarter	(Oct 03 2025) III. Quarter	(Jul 04 2025) II. Quarter
Y / Y Revenue Change	10.63 %	9.97 %	5.63 %	10.79 %	-10.82 %
Sales per Employee (TTM) $	2,123,731	2,071,047	2,022,778	1,994,959	1,944,207
EXEL's Total Ranking	# 414	# 282	# 111	# 203	# 43
Seq. Revenue Change	2.93 %	2.03 %	0.15 %	5.19 %	2.31 %

EXEL Company Profile >> Back to EXEL Efficiency Comparisons >> Compare EXEL Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 4
Healthcare Sector	# 29
Overall Market	# 414

Revenue per Employee Statistics
High	Average	Low
$ 2,123,731	$ 797,227	$ 18,553
(Jul 03 2026)		(Jun 30 2014)

Financial Statements
Exelixis Inc 's Revenue MRQ	$ 629 Millions	Visit EXEL's Income Statement
Exelixis Inc 's Revenues TTM	$ 2,436 Millions	Visit EXEL's aggregate revenue growth
What are EXEL's Sales?		Visit EXEL's Sales by Segment

Other Ratios
Exelixis Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
EXEL's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for EXEL's Competitors
Revenue per Employee for EXEL's Suppliers
Revenue per Employee for EXEL's Customers

You may also want to know
EXEL's Sales Growth Rates	EXEL's Pe Price to earnings ratio	EXEL's Receivables Turnover Ratio	EXEL's Stock Quote
EXEL's Net Income Growth Rates	EXEL's Ps Price to Sales ratio	EXEL's Sales per Employee	EXEL's Asset Turnover Ratio
EXEL's Net Margin	EXEL's Pb Price to Book ratio	EXEL's Financial Strength Ratios	EXEL's Dividend Payout Ratio

Date modified: 2026-09-13T23:29:29+00:00

Companies with similar Revenue per Employee for 12 months ending Jul 03 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jul 03 2026	Number of Employees Jul 03 2026
Illumina Inc	3,510,156.25	$ 4,493.000 Million	1,280
Harmony Biosciences Holdings inc	3,277,102.39	$ 960.191 Million	293
Therapeuticsmd Inc	3,270,000.00	$ 3.270 Million	1
Amgen Inc	2,930,384.62	$ 38,095.000 Million	13,000
Innoviva Inc	2,645,471.70	$ 420.630 Million	159
Aurinia Pharmaceuticals Inc	2,433,648.44	$ 311.507 Million	128
Eton Pharmaceuticals Inc	2,392,704.55	$ 105.279 Million	44
Cormedix Inc	2,366,196.28	$ 451.943 Million	191
Sarepta Therapeutics Inc	2,364,483.83	$ 1,974.344 Million	835
United Therapeutics Corporation	2,253,214.29	$ 3,154.500 Million	1,400
Biocryst Pharmaceuticals Inc	2,162,328.74	$ 940.613 Million	435
Elite Pharmaceuticals Inc	2,155,839.86	$ 140.130 Million	65
Protagonist Therapeutics inc	2,136,303.03	$ 281.992 Million	132
Exelixis Inc	2,123,731.47	$ 2,435.920 Million	1,147
Zevra Therapeutics Inc	2,112,377.05	$ 128.855 Million	61
Liquidia Corporation	2,087,532.41	$ 450.907 Million	216
Tg Therapeutics Inc	2,003,849.62	$ 799.536 Million	399
Prestige Consumer Healthcare Inc	1,938,521.05	$ 1,104.957 Million	570
Privia Health Group Inc	1,923,384.18	$ 2,358.069 Million	1,226
Alnylam Pharmaceuticals Inc	1,921,672.80	$ 4,804.182 Million	2,500
Gilead Sciences Inc	1,791,588.24	$ 30,457.000 Million	17,000
Collegium Pharmaceutical Inc	1,777,172.58	$ 751.744 Million	423
Fennec Pharmaceuticals Inc	1,692,028.57	$ 59.221 Million	35
Neurocrine Biosciences Inc	1,686,950.00	$ 3,373.900 Million	2,000
Mirum Pharmaceuticals Inc	1,661,470.43	$ 618.067 Million	372
Tarsus Pharmaceuticals Inc	1,638,732.43	$ 606.331 Million	370
Agenus Inc	1,638,185.19	$ 132.693 Million	81
Xenetic Biosciences Inc	1,630,388.50	$ 3.261 Million	2
Ideaya Biosciences Inc	1,614,668.97	$ 234.127 Million	145
Eli Lilly And Company	1,593,316.00	$ 79,665.800 Million	50,000

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.